Trial Outcomes & Findings for Adherence to Medical Treatments for Telemedicine Patients (NCT NCT04180475)
NCT ID: NCT04180475
Last Updated: 2024-03-19
Results Overview
Assess the patients' adherence to medications and exercise. Adherence will be measured by patient responses to questions prompted by the MedRem System.
TERMINATED
NA
5 participants
30 days
2024-03-19
Participant Flow
Participant milestones
| Measure |
MedRem Application
MedRem smartwatch application
MedRem application: Medication adherence smartwatch application
|
|---|---|
|
Overall Study
STARTED
|
5
|
|
Overall Study
COMPLETED
|
5
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
MedRem Application
n=5 Participants
MedRem smartwatch application
MedRem application: Medication adherence smartwatch application
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
5 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
3 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 30 daysPopulation: No data were collected for this Outcome Measure
Assess the patients' adherence to medications and exercise. Adherence will be measured by patient responses to questions prompted by the MedRem System.
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: 30 daysPopulation: No data were collected for this Outcome Measure
Acceptance and usability will be measured by the Intervention Patient MedRem Usability Survey. Steps were taken and distance covered data will also be collected from the Apple Watch.
Outcome measures
Outcome data not reported
Adverse Events
MedRem Application
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place